News
Newly classified Type-5 diabetes, linked to malnutrition, affects millions globally. Learn about its symptoms, diagnosis, and ...
Given the success of the previous collection, Digital Technology in the Management and Prevention of Diabetes: Volume II, we are pleased to announce the ...
Stroke continues to be a leading cause of long-term disability worldwide, necessitating a coordinated approach that extends beyond the acute care phase.
At age 21, Dr Magdalena Garcia started her career as a nurse at the KHMH. 21 years later, she is still employed at the hospital, except now she has been trained as a general surgeon.
We already know we can’t count on tech platforms to tackle disinformation, so we need better regulations, Filipe Pardal of ...
The drug helped lower patients’ blood sugar and reduce their weight by an average of 16 pounds.
A daily pill from drugmaker Eli Lilly has shown safety results comparable to the leading injectable GLP-1 drugs Mounjaro and ...
Oral semaglutide cuts major heart risks in people with type 2 diabetes by 14%, offering a powerful pill-based option. Both ...
Apr. 8, 2025 — Research shows that the biological parents' genes affect the child's insulin function and capacity to regulate blood sugar levels and blood lipids in different ways. Such ...
A study led by researchers in the University of Florida College of Pharmacy has found that a pair of popular glucose-lowering medications may have protective effects against the development of ...
Eli Lilly said clinical results of its GLP-1 in pill form showed safety ... 559 people with Type 2 diabetes who took the new pill or a placebo for 40 weeks. In patients who took orforglipron ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results